Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Apr-24 4:22 PM View:  | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 3,988 | -- | -- | < 1% 4.1M to 4.1M | |
| 28-Mar-24 7:04 PM View: | Igm Biosciences, Inc. (IGMS) | 28-Mar-24 | Purchase | 97,473 | $9.62 | $937,632.00 | 2% 4.0M to 4.1M | |
| 01-Apr-24 4:26 PM View: | Incyte Corp (INCY) | 28-Mar-24 | Grant | 1,086 | -- | -- | < 1% 37.01M to 37.01M | |
| 28-Mar-24 7:04 PM View: | Igm Biosciences, Inc. (IGMS) | 27-Mar-24 | Purchase | 27,844 | $9.24 | $257,170.00 | < 1% 3.98M to 4.0M | |
| 28-Mar-24 7:04 PM View: | Igm Biosciences, Inc. (IGMS) | 26-Mar-24 | Private Purchase | 270,000 | $8.26 | $2,230,770.00 | 7% 3.71M to 3.98M | |
| 07-Mar-24 4:53 PM View: | vTv Therapeutics Inc. (VTVT) | 05-Mar-24 | Disposition | 57,657 | -- | -- | (37%) 154.97K to 97.31K | |
| 03-Jan-24 6:02 PM View: | Igm Biosciences, Inc. (IGMS) | 29-Dec-23 | Grant | 1,108 | -- | -- | < 1% 3.7M to 3.71M | |
| 03-Jan-24 5:58 PM View: | Incyte Corp (INCY) | 29-Dec-23 | Grant | 1,112 | -- | -- | < 1% 37.01M to 37.01M | |
| 15-Dec-23 5:32 PM View: | Igm Biosciences, Inc. (IGMS) | 15-Dec-23 | Purchase | 288,007 | $6.55 | $1,887,530.00 | 8% 3.42M to 3.7M | |
| 18-Dec-23 6:46 PM View: | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 46,557 | $229.00 | $10,661,600.00 | (< 1%) 44.76M to 44.71M | |
| 18-Dec-23 6:46 PM View: | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 44,708,500 | $229.00 | $10,238,199,808.00 | (100%) 44.71M to 0 | |
| 15-Dec-23 5:32 PM View: | Igm Biosciences, Inc. (IGMS) | 14-Dec-23 | Purchase | 157,370 | $6.50 | $1,023,160.00 | 5% 3.26M to 3.42M | |
| 14-Dec-23 6:10 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 14-Dec-23 | Purchase | 20,633 | $228.32 | $4,710,890.00 | < 1% 3.75M to 3.77M | |
| 15-Dec-23 5:32 PM View: | Igm Biosciences, Inc. (IGMS) | 13-Dec-23 | Private Purchase | 87,316 | $5.96 | $520,776.00 | 3% 3.17M to 3.26M | |
| 14-Dec-23 6:10 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 13-Dec-23 | Purchase | 81,159 | $219.39 | $17,805,700.00 | 4% 2.06M to 2.14M | |
| 14-Dec-23 6:09 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 12-Dec-23 | Purchase | 34,578 | $218.31 | $7,548,620.00 | 2% 1.84M to 1.88M | |
| 24-Nov-23 1:39 PM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 22-Nov-23 | Exercise (in-the money or at-the-money) | 2,116,350 | $0.00 | $211.63 | 850% 249.12K to 2.37M | |
| 21-Nov-23 6:15 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 21-Nov-23 | Purchase | 64,350 | $188.48 | $12,128,300.00 | 4% 1.78M to 1.84M | |
| 21-Nov-23 6:14 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 20-Nov-23 | Purchase | 20,709 | $185.74 | $3,846,580.00 | 1% 1.76M to 1.78M | |
| 21-Nov-23 6:14 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 17-Nov-23 | Purchase | 46,370 | $174.70 | $8,100,700.00 | 3% 1.71M to 1.76M | |
| 15-Nov-23 5:13 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 15-Nov-23 | Purchase | 15,199 | $161.97 | $2,461,720.00 | < 1% 1.7M to 1.71M | |
| 15-Nov-23 5:12 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 14-Nov-23 | Purchase | 37,660 | $154.00 | $5,799,650.00 | 2% 1.62M to 1.66M | |
| 15-Nov-23 5:13 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 14-Nov-23 | Purchase | 34,188 | $156.42 | $5,347,840.00 | 2% 1.66M to 1.7M | |
| 14-Nov-23 10:00 PM View: | Beigene, Ltd. (BGNE) | 14-Nov-23 | Sale | 1,100,000 | $180.50 | $198,550,000.00 | (9%) 11.87M to 10.77M | |
| 15-Nov-23 5:12 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 13-Nov-23 | Purchase | 69,839 | $143.21 | $10,001,400.00 | 4% 1.55M to 1.62M | |
| 23-Oct-23 4:49 PM View: | Atreca, Inc. (BCEL) | 19-Oct-23 | Sale | 274,739 | $0.40 | $110,582.00 | (8%) 3.53M to 3.26M | |
| 10-Oct-23 4:22 PM View: | Neurogene Inc. (NGNE) | 05-Oct-23 | Exercise (in-the money or at-the-money) | 592,650 | -- | -- | 48% 1.22M to 1.81M | |
| 17-Aug-23 5:08 PM View: | Neurogene Inc. (NGNE) | 17-Aug-23 | Purchase | 166,942 | $0.69 | $115,617.00 | 3% 5.94M to 6.11M | |
| 17-Aug-23 5:08 PM View: | Neurogene Inc. (NGNE) | 16-Aug-23 | Purchase | 229,600 | $0.68 | $156,254.00 | 4% 5.72M to 5.94M | |
| 17-Aug-23 5:08 PM View: | Neurogene Inc. (NGNE) | 15-Aug-23 | Private Purchase | 1,888,800 | $0.63 | $1,191,620.00 | 49% 3.83M to 5.72M | |
| 05-Jul-23 5:05 PM View: | Igm Biosciences, Inc. (IGMS) | 30-Jun-23 | Grant | 1,108 | -- | -- | < 1% 3.17M to 3.17M | |
| 05-Jul-23 5:04 PM View: | Incyte Corp (INCY) | 30-Jun-23 | Grant | 1,024 | -- | -- | < 1% 36.73M to 36.73M | |
| 20-Jun-23 4:10 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 15-Jun-23 | Grant | 9,584 | -- | -- | < 1% 1.55M to 1.55M | |
| 16-Jun-23 4:02 PM View: | Incyte Corp (INCY) | 14-Jun-23 | Grant | 5,010 | -- | -- | < 1% 36.72M to 36.73M | |
| 08-Jun-23 5:37 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 06-Jun-23 | Grant | 17,492 | -- | -- | < 1% 2.83M to 2.85M | |
| 05-Jun-23 5:14 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 01-Jun-23 | Grant | 26,608 | -- | -- | < 1% 43.03M to 43.06M | |
| 02-Jun-23 9:30 PM View: | Seattle Genetics Inc. (SGEN) | 31-May-23 | Grant | 4,088 | -- | -- | < 1% 44.73M to 44.73M | |
| 24-May-23 5:09 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 24-May-23 | Purchase | 553,263 | $25.48 | $14,096,800.00 | < 1% 84.64M to 85.2M | |
| 24-May-23 5:09 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 23-May-23 | Option Exercise | 25,000 | $17.01 | $425,250.00 | < 1% 84.41M to 84.43M | |
| 24-May-23 5:09 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 23-May-23 | Purchase | 209,053 | $25.41 | $5,312,460.00 | < 1% 84.43M to 84.64M | |
| 24-May-23 5:09 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 22-May-23 | Market Purchase | 134,206 | $24.57 | $3,297,810.00 | < 1% 84.25M to 84.38M | (8%) |
| 03-May-23 4:04 PM View: | Seattle Genetics Inc. (SGEN) | 02-May-23 | Gift | 418,350 | -- | -- | (< 1%) 49.24M to 48.83M | |
| 03-May-23 4:04 PM View: | Seattle Genetics Inc. (SGEN) | 01-May-23 | Acquisition (other) | 418,350 | -- | -- | < 1% 50.97M to 51.39M | |
| 03-May-23 4:04 PM View: | Seattle Genetics Inc. (SGEN) | 01-May-23 | Disposition (other) | 2,368,360 | -- | -- | (5%) 51.4M to 49.03M | |
| 03-May-23 4:04 PM View: | Seattle Genetics Inc. (SGEN) | 01-May-23 | Option Exercise | 17,500 | $36.70 | $642,250.00 | < 1% 51.39M to 51.4M | |
| 04-Apr-23 3:57 PM View: | Igm Biosciences, Inc. (IGMS) | 31-Mar-23 | Grant | 1,108 | -- | -- | < 1% 3.17M to 3.17M | |
| 04-Apr-23 3:59 PM View: | Incyte Corp (INCY) | 31-Mar-23 | Grant | 858 | -- | -- | < 1% 36.72M to 36.72M | |
| 15-Mar-23 4:03 PM View: | Incyte Corp (INCY) | 13-Mar-23 | Option Exercise | 40,000 | $22.74 | $909,600.00 | < 1% 36.68M to 36.72M | |
| 17-Jan-23 4:22 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 12-Jan-23 | Option Exercise | 30,000 | $5.22 | $156,600.00 | < 1% 42.08M to 42.11M | |
| 04-Jan-23 4:02 PM View: | Incyte Corp (INCY) | 30-Dec-22 | Grant | 794 | -- | -- | < 1% 36.68M to 36.68M |